glucose, (beta-d)-isomer has been researched along with substance p in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.25) | 18.7374 |
1990's | 7 (43.75) | 18.2507 |
2000's | 4 (25.00) | 29.6817 |
2010's | 3 (18.75) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Betts, WH; McLennan, G; Scicchitano, R; Wozniak, A | 1 |
Bar-Shavit, Z; Goldman, R | 1 |
Calzetti, F; Cassatella, MA; Ceska, M; Serra, MC | 1 |
Frendl, G; Reenstra, WR; Stahl, GL | 1 |
Braun, M; Hohlfeld, T; Kienbaum, P; Sarbia, M; Schrör, K; Weber, AA | 1 |
Bambara, LM; Bellavite, P; Biasi, D; Caraffi, M; Carletto, A; Chirumbolo, S; Serra, MC | 1 |
Cascieri, MA; Cichy-Knight, MA; Hirschmann, R; Hynes, J; Maechler, L; Smith, AB; Sprengeler, PA; Strader, CD; van Rijn, RD; Yao, W | 1 |
Calixto, JB; Campos, MM; Cechinel Filho, V; Mendes, GL; Santos, AR; Tratsk, KS; Yunes, RA | 1 |
Al-Rashed, S; Brain, SD; Cao, T; Gerard, N; Hoult, JR; Pintér, E | 1 |
Franzyk, H; Frederiksen, SM; Jensen, SR | 1 |
Cantin, LD; Cascieri, MA; Chicchi, G; Hirschmann, R; Liu, J; Rohrer, SP; Smith, AB; Underwood, DJ | 1 |
Cahill, CM; Henry, JL; Landau, AM; Ribeiro-da-Silva, A; St Louis, M; Yashpal, K | 1 |
DeBerry, J; Ness, TJ; Randich, A; Robbins, MT; Shaffer, AD | 1 |
Chen, CY; Chen, WY; Chen, YJ; Chou, CC; Chung, TY; Lee, MR; Lin, NH; Lo, YH; Tzen, JT | 1 |
Chen, F; Ji, J; Xie, G; Xu, S; Zhang, Y; Zhu, F | 1 |
Guo, X; Qin, Z; Wei, B; Wu, Q; Wu, R; Wu, W; Xiao, H; Zhang, H | 1 |
16 other study(ies) available for glucose, (beta-d)-isomer and substance p
Article | Year |
---|---|
The effect of substance P on neutrophil function in normal and asthmatic subjects.
Topics: Antibody-Dependent Cell Cytotoxicity; Asthma; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Substance P; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1992 |
Substance P and neurotensin.
Topics: Animals; Cells, Cultured; Iodine Radioisotopes; Macrophages; Mice; Neurotensin; Phagocytosis; Radioisotope Dilution Technique; Substance P; Tritium; Zymosan | 1986 |
Effect of substance P on superoxide anion and IL-8 production by human PMNL.
Topics: Concanavalin A; Drug Interactions; Humans; Interleukin-8; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; RNA, Messenger; Substance P; Superoxides; Tumor Necrosis Factor-alpha; Zymosan | 1994 |
Complement-mediated loss of endothelium-dependent relaxation of porcine coronary arteries. Role of the terminal membrane attack complex.
Topics: Animals; Bradykinin; Complement Activation; Complement Membrane Attack Complex; Complement Pathway, Alternative; Coronary Vessels; Endothelium, Vascular; Humans; Immunohistochemistry; In Vitro Techniques; Myocardial Ischemia; Myocardial Reperfusion; Nitric Oxide; Receptors, Complement; Substance P; Swine; Vasodilation; Zymosan | 1995 |
Antiatherosclerotic effects of oral naftidrofuryl in cholesterol-fed rabbits involve inhibition of neutrophil function.
Topics: Acetylcholine; Administration, Oral; Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Endothelium, Vascular; Fibrinogen; Luminescent Measurements; Luminol; Male; Molsidomine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nafronyl; Neutrophils; Nitric Oxide; Rabbits; Random Allocation; Substance P; Vasodilator Agents; Zymosan | 1995 |
Factor-specific changes in oxidative burst response of human neutrophils in skin-window exudates.
Topics: Concanavalin A; Exudates and Transudates; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxygen Consumption; Respiratory Burst; Skin Window Technique; Sodium Fluoride; Substance P; Superoxides; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Zymosan | 1993 |
Synthesis of potent cyclic hexapeptide NK-1 antagonists. Use of a minilibrary in transforming a peptidal somatostatin receptor ligand into an NK-1 receptor ligand via a polyvalent peptidomimetic.
Topics: Amino Acid Sequence; Chromatography, High Pressure Liquid; Drug Design; Glucosides; Inositol Phosphates; Ligands; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Molecular Structure; Neurokinin-1 Receptor Antagonists; Oligopeptides; Peptides, Cyclic; Receptors, Neurokinin-1; Receptors, Somatostatin; Somatostatin; Substance P | 1996 |
Anti-hyperalgesic properties of the extract and of the main sesquiterpene polygodial isolated from the barks of Drymis winteri (Winteraceae).
Topics: Abdominal Pain; Acetic Acid; Animals; Bradykinin; Capsaicin; Disease Models, Animal; Dose-Response Relationship, Drug; Formaldehyde; Hyperalgesia; Male; Mice; Motor Activity; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar; Sesquiterpenes; Substance P; Zymosan | 1998 |
Neurokinin-1 receptor agonists are involved in mediating neutrophil accumulation in the inflamed, but not normal, cutaneous microvasculature: an in vivo study using neurokinin-1 receptor knockout mice.
Topics: Animals; Bradykinin; Bradykinin Receptor Antagonists; Carrageenan; Cell Movement; Drug Combinations; Female; Injections, Intradermal; Injections, Intravenous; Interleukin-1; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Neutrophils; Receptors, Neurokinin-1; Skin; Substance P; Zymosan | 2000 |
Conversion of the iridoid glucoside antirrhinoside into 3-azabicyclo[3.3.0]octane building blocks.
Topics: Aza Compounds; Bridged Bicyclo Compounds; Glucosides; Hypoglycemic Agents; Indicators and Reagents; Iridoid Glucosides; Iridoids; Pyrans; Substance P | 2000 |
Synthesis of a substance P antagonist with a somatostatin scaffold: factors affecting agonism/antagonism at GPCRs and the role of pseudosymmetry.
Topics: Animals; CHO Cells; COS Cells; Cricetinae; Glucosides; Humans; Membrane Proteins; Molecular Mimicry; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Receptors, Somatostatin; Somatostatin; Substance P | 2000 |
Sensory neuron and substance P involvement in symptoms of a zymosan-induced rat model of acute bowel inflammation.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Colitis; Colon; Disease Models, Animal; Enteric Nervous System; Ethanol; Inflammation Mediators; Male; Neurogenic Inflammation; Neurokinin-1 Receptor Antagonists; Neurons, Afferent; Oligonucleotides, Antisense; Pain; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; RNA, Messenger; Substance P; Sympathetic Nervous System; Zymosan | 2007 |
Neonatal bladder inflammation produces functional changes and alters neuropeptide content in bladders of adult female rats.
Topics: Aging; Animals; Animals, Newborn; Calcitonin Gene-Related Peptide; Cystitis; Disease Models, Animal; Evans Blue; Female; Irritants; Mustard Plant; Neuropeptides; Nociceptors; Plant Oils; Rats; Sensory Receptor Cells; Substance P; Time; Urinary Bladder; Zymosan | 2010 |
Emoghrelin, a unique emodin derivative in Heshouwu, stimulates growth hormone secretion via activation of the ghrelin receptor.
Topics: Animals; Cell Line, Tumor; Cell Survival; Cells, Cultured; Emodin; Glucosides; Growth Hormone; Humans; Male; Molecular Docking Simulation; Oligopeptides; Pituitary Gland, Anterior; Plant Roots; Plants, Medicinal; Polygonum; Rats, Sprague-Dawley; Receptors, Ghrelin; Substance P | 2015 |
Total Glucosides of Paeony Promote Intestinal Motility in Slow Transit Constipation Rats through Amelioration of Interstitial Cells of Cajal.
Topics: Animals; Constipation; Disease Models, Animal; Female; Gastrointestinal Motility; Glucosides; Interstitial Cells of Cajal; Neurotransmitter Agents; Nitric Oxide; Nitric Oxide Synthase; Paeonia; Prospective Studies; Proto-Oncogene Proteins c-kit; Rats; Rats, Wistar; Stem Cell Factor; Substance P; Vasoactive Intestinal Peptide | 2016 |
Glucose-Dependent Insulinotropic Polypeptide and Substance P Mediate Emetic Response Induction by Masked Trichothecene Deoxynivalenol-3-Glucoside through Ca
Topics: Animals; Emetics; Glucose; Glucosides; Mink; Receptors, G-Protein-Coupled; Receptors, Gastrointestinal Hormone; Substance P; Trichothecenes; Vomiting | 2022 |